Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.8.0.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2018
Accounting Policies [Abstract]  
Schedule of reconciliation of cash, cash equivalents and restricted cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated statements of financial position that sum to the total of the same amounts shown in the condensed consolidated statement of cash flows (in thousands):

 

    March 31, 2017  
       
Current assets        
Cash and cash equivalents   $ 30,113  
Restricted cash     576  
         
Total cash, cash equivalents and restricted        
cash shown in the statement of cash flows   $ 30,689  
Schedule of computation of potentially dilutive securities

For all periods presented in this report, convertible notes, stock options, and warrants were not included in the computation of diluted net loss per share because such inclusion would have had an antidilutive effect.

 

    Three months ended  
    March 31,  
Excluded potentially dilutive securities (1):   2018     2017  
             
Convertible note - principal     702,247       702,247  
Consulting warrants to purchase common stock           12,500  
Options to purchase common stock     561,536       892,129  
Unvested restricted stock     63,600        
Financing warrants to purchase common stock     2,340,828       2,384,464  
Total potential dilutive securities     3,668,211       3,991,340  

 

  (1) The number of shares is based on the maximum number of shares issuable on exercise or conversion of the related securities as of the period end. Such amounts have not been adjusted for the treasury stock method or weighted average outstanding calculations as required if the securities were dilutive.